Log In
BCIQ
Print this Print this
 

LY2409021

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionGlucagon receptor antagonist
Molecular Target Glucagon receptor (GCGR)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today